| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |